The Influencing Factors Associated with Ketosis-Prone Type 2 Diabetes Mellitus: A Syndrome of Diabetes Mellitus
International Journal of Diabetes and Endocrinology
Volume 3, Issue 1, March 2018, Pages: 1-6
Received: Feb. 21, 2018; Accepted: Mar. 9, 2018; Published: Apr. 3, 2018
Views 973      Downloads 84
Authors
Md Rezaul Karim, Department of Neurology, Taihe Hospital of Hubei University of Medicine, Shiyan, China
Afsarunnesa Syeda, Department of Gynecology & Obstetrics, Renmin Hospital of Hubei University of Medicine, Shiyan, China
Article Tools
Follow on us
Abstract
Ketosis-prone diabetes or KPD is an intermediate form of diabetes and is a widespread syndrome. To review the influencing factors of ketosis in type 2 diabetes (T2DK), All patients of ketosis with type 2 diabetes are studied under single entity as the method. In this review, we described the current state of knowledge in regard to Ethnicity, age, sex, family history, infection, obesity, Dyslipidemia, and Hyperglycemia is associated as the influencing factors in Ketosis-Prone Type 2 Diabetes Mellitus.
Keywords
Type 2 Diabetes, Ketosis, Ketosis in Type 2 Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis
To cite this article
Md Rezaul Karim, Afsarunnesa Syeda, The Influencing Factors Associated with Ketosis-Prone Type 2 Diabetes Mellitus: A Syndrome of Diabetes Mellitus, International Journal of Diabetes and Endocrinology. Vol. 3, No. 1, 2018, pp. 1-6. doi: 10.11648/j.ijde.20180301.11
Copyright
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Karges, B., Rosenbauer, J., Holterhus, P., Beyer, P., Seithe, H., & Vogel, C. (2015). Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31 330 young patients with type 1 diabetes. European Journal of Endocrinology, 173(3), 341-350. doi:10.1530/eje-15-0129
[2]
Amiel, S. A., Pursey, N., Higgins, B., & Dawoud, D. (2015). Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance. BMJ, h4188. doi:10.1136/bmj.h4188
[3]
Goodstein, G., Milanesi, A., & Weinreb, J. E. (2014). Ketosis-Prone Type 2 Diabetes in a Veteran Population. Diabetes Care, 37(4), e74-e75. doi:10.2337/dc13-2824
[4]
Kim, M. K., Lee, S. H., Kim, J. H., Lee, J. I., Kim, J. H., Jang, E. H., … Song, K. (2009). Clinical characteristics of Korean patients with new-onset diabetes presenting with diabetic ketoacidosis. Diabetes Research and Clinical Practice, 85(1), e8-e11. doi:10.1016/j.diabres.2009.04.017
[5]
Umpierrez, G. E. (2006). Ketosis-Prone Type 2 Diabetes: Time to revise the classification of diabetes. Diabetes Care, 29(12), 2755-2757. doi:10.2337/dc06-1870
[6]
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006). Narrative Review: Ketosis-Prone Type 2 Diabetes Mellitus. Annals of Internal Medicine, 144(5), 350. doi:10.7326/0003-4819-144-5-200603070-00011
[7]
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J., Kevorkian, J., Vaisse, C., … Gautier, J. (2004). Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin: Clinical Pathophysiology and Natural History of -Cell Dysfunction and Insulin Resistance. Diabetes, 53(3), 645-653. doi:10.2337/diabetes.53.3.645
[8]
Balasubramanyam, A., Zern, J. W., Hyman, D. J., & Pavlik, V. (1999). New Profiles of Diabetic Ketoacidosis. Archives of Internal Medicine, 159(19). doi:10.1001/archinte.159.19.2317
[9]
Tan, K. C., Mackay, I. R., Zimmet, P. Z., Hawkins, B. R., & Lam, K. S. (2000). Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care, 23(3), 335-338. doi:10.2337/diacare.23.3.335
[10]
Tan, H., Zhou, Y., & Yu, Y. (2012). Characteristics of diabetic ketoacidosis in Chinese adults and adolescents – A teaching hospital-based analysis. Diabetes Research and Clinical Practice, 97(2), 306-312. doi:10.1016/j.diabres.2012.05.004
[11]
Liu, B., Yu, C., Li, Q., & Li, L. (2013). Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not? International Journal of Endocrinology, 2013, 1-6. doi:10.1155/2013/821403
[12]
Nagasaka, S., Ishikawa, S., Itabashi, N., Rokkaku, K., & Saito, T. (1998). Ketoacidosis-Onset Type 2 Diabetes in Japanese: Association with the widespread distribution of soft drinks and vending machines. Diabetes Care, 21(8), 1376-1377. doi:10.2337/diacare.21.8.1376
[13]
Jabbar, A., Farooqui, K., Habib, A., Islam, N., Haque, N., & Akhter, J. (2004). Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with Type 2 diabetes mellitus. Diabetic Medicine, 21(8), 920-923. doi:10.1111/j.1464-5491.2004.01249.x
[14]
Sellers, E. A., & Dean, H. J. (2000). Diabetic ketoacidosis: a complication of type 2 diabetes in Canadian aboriginal youth. Diabetes Care, 23(8), 1202-1204. doi:10.2337/diacare.23.8.1202
[15]
Kitabchi, A. E. (2003). Ketosis-Prone Diabetes—A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes? The Journal of Clinical Endocrinology & Metabolism, 88(11), 5087-5089. doi:10.1210/jc.2003-031656
[16]
Smiley, D., Chandra, P., & Umpierrez, G. E. (2011). Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Diabetes Management, 1(6), 589-600. doi:10.2217/dmt.11.57
[17]
Du, S., Yang, X., Shi, D., & Su, Q. (2016). Characteristics of Type 2 Diabetes with Ketosis in Baoshan, Yunnan of China. Journal of Diabetes Research, 2016, 1-5. doi:10.1155/2016/7854294
[18]
Zhou, Y. X., & Tan, H. W. (2013). Clinical features and epidemiological trend of diabetic ketosis in patients admitted to West China Hospital. Sichuan Da Xue Xue Bao Yi Xue Ban, 44, 950-953.
[19]
Piñero-Piloña, A., & Raskin, P. (2001). Idiopathic Type 1 diabetes. Journal of Diabetes and its Complications, 15(6), 328-335. doi:10.1016/s1056-8727(01)00172-6
[20]
Wang, X., & Tan, H. (2015). Male predominance in ketosis-prone diabetes mellitus. Biomedical Reports, 3(4), 439-442. doi:10.3892/br.2015.461
[21]
Maldonado, M., Hampe, C. S., Gaur, L. K., D’Amico, S., Iyer, D., Hammerle, L. P., … Balasubramanyam, A. (2003). Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and β-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes. The Journal of Clinical Endocrinology & Metabolism, 88(11), 5090-5098. doi:10.1210/jc.2003-030180
[22]
Vaibhav, A., Mathai, M., & Gorman, S. (2013). Atypical diabetes in children: ketosis-prone type 2 diabetes. Case Reports, 2013(jan08 1), bcr2012007704-bcr2012007704. doi:10.1136/bcr-2012-007704
[23]
Matsui, J., Tamasawa, N., Tanabe, J., Kasai, N., Murakami, H., Matsuki, K., & Suda, T. (2005). Clinical characteristics of Japanese youth-onset type 2 diabetes with ketonuria. Diabetes Research and Clinical Practice, 70(3), 235-238. doi:10.1016/j.diabres.2005.03.037
[24]
Seok, H., Jung, C. H., Kim, S. W., Lee, M. J., Lee, W. J., Kim, J. H., & Lee, B. (2013). Clinical characteristics and insulin independence of Koreans with new-onset type 2 diabetes presenting with diabetic ketoacidosis. Diabetes/Metabolism Research and Reviews, 29(6), 507-513. doi:10.1002/dmrr.2421
[25]
Ekpebegh, C., Longo-Mbenza, B., & Blanco-Blanco, E. (2014). OP9 Islet immunity and beta cell reserve of indigenous Black South Africans with ketoacidosis at initial diagnosis of diabetes. Diabetes Research and Clinical Practice, 103, S11. doi:10.1016/s0168-8227(14)70036-1
[26]
Pitteloud, N., & Philippe, J. (2000). Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr, 130(16), 576-582.
[27]
Umpierrez, G. E., Smiley, D., Robalino, G., Peng, L., Gosmanov, A. R., & Kitabchi, A. E. (2009). Lack of Lipotoxicity Effect on -Cell Dysfunction in Ketosis-Prone Type 2 Diabetes. Diabetes Care, 33(3), 626-631. doi:10.2337/dc09-1369
[28]
Zhu, B., Bu, L., Zhang, M., Gusdon, A. M., Zheng, L., Rampersad, S., … Qu, S. (2016). HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus. Scientific Reports, 6(1). doi:10.1038/srep39687
[29]
Porte, D., & Kahn, S. E. (2001). Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes, 50(Supplement 1), S160-S163. doi:10.2337/diabetes.50.2007.s160
[30]
Steppel, J. H., & Horton, E. S. (2004). Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Current Diabetes Reports, 4(3), 169-175. doi:10.1007/s11892-004-0019-3
[31]
Brunner, Y., Schvartz, D., Priego-Capote, F., Couté, Y., & Sanchez, J. (2009). Glucotoxicity and pancreatic proteomics. Journal of Proteomics, 71(6), 576-591. doi:10.1016/j.jprot.2008.10.002
[32]
Sobngwi, E., Mauvais-Jarvis, F., Vexiau, P., Mbanya, J. C., & Gautier, J. F. (2002). Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes Metab, 28(1), 5-12.
[33]
Carpentier, A., Mittelman, S. D., Lamarche, B., Bergman, R. N., Giacca, A., & Lewis, G. F. (1999). Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. American Journal of Physiology-Endocrinology and Metabolism, 276(6), E1055-E1066. doi:10.1152/ajpendo.1999.276.6.e1055
[34]
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic Crises in Adult Patients with Diabetes. Diabetes Care, 32(7), 1335-1343. doi:10.2337/dc09-9032
[35]
Gosmanov, A. R., Umpierrez, G. E., Karabell, A. H., Cuervo, R., & Thomason, D. B. (2004). Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. American Journal of Physiology-Endocrinology and Metabolism, 287(1), E8-E15. doi:10.1152/ajpendo.00485.2003
[36]
Kitamura, T., Feng, Y., Ido Kitamura, Y., Chua, S. C., Xu, A. W., Barsh, G. S., … Accili, D. (2006). Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nature Medicine, 12(5), 534-540. doi:10.1038/nm1392
[37]
Zhang, M., Li, Y., Cui, W., Yang, P., Li, H., Sheng, C., … Qu, S. (2015). The Clinical and Metabolic Characteristics of Young-Onset Ketosis-Prone Type 2 Diabetes In China. Endocrine Practice, 21(12), 1364-1371. doi:10.4158/ep15778.or
[38]
Du, S., Yang, X., Shi, D., & Su, Q. (2016). Comparison between New-Onset and Old-Diagnosed Type 2 Diabetes with Ketosis in Rural Regions of China. International Journal of Endocrinology, 2016, 1-5. doi:10.1155/2016/3010243
[39]
Tan, H. H., Lim, H. S., & Lim, S. C. (2001). Severe diabetes in remission: a Singapore’s perspective. Annals Academy of Medicine Singapore, 30, 615-619.
[40]
Algoblan, A., Alalfi, M., & Khan, M. (2014). Mechanism linking diabetes mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 587. doi:10.2147/dmso.s67400
[41]
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(7121), 840-846. doi:10.1038/nature05482
[42]
Fernandez, C., Gimenez, M., Diaz, G., & Conget, I. (2007). Accuracy and Predictive Value of Classification Schemes for Ketosis-Prone Diabetes: Response to Balasubramanyam et al. Diabetes Care, 30(9), e96-e96. doi:10.2337/dc07-0400
[43]
Sobngwi, E. (2008). Ketosis-Prone Type 2 Diabetes Mellitus and Human Herpesvirus 8Infection in Sub-Saharan Africans. JAMA, 299(23), 2770. doi:10.1001/jama.299.23.2770
[44]
Nguewa, J., Lontchi-Yimagou, E., Agbelika, F., AitDjoudi, M., Boudou, P., Choukem, S., … Gautier, J. (2017). Relationship between HHV8 infection markers and insulin sensitivity in ketosis-prone diabetes. Diabetes & Metabolism, 43(1), 79-82. doi:10.1016/j.diabet.2016.05.004
[45]
Järviluoma, A., & Ojala, P. M. (2006). Cell signaling pathways engaged by KSHV. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1766(1), 140-158. doi:10.1016/j.bbcan.2006.05.001
[46]
Tan, H., Wang, C., & Yu, Y. (2012). H1N1 Influenza: The Trigger of Diabetic Ketoacidosis in a Young Woman with Ketosis-Prone Diabetes. The American Journal of the Medical Sciences, 343(2), 180-183. doi:10.1097/maj.0b013e3182376cc4
[47]
Li, J., Huang, M., & Shen, X. (2014). The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. Journal of Diabetes and its Complications, 28(5), 662-666. doi:10.1016/j.jdiacomp.2014.06.008
[48]
Hoffman, W. H., Burek, C., Waller, J. L., Fisher, L. E., Khichi, M., & Mellick, L. B. (2003). Cytokine response to diabetic ketoacidosis and its treatment. Clinical Immunology, 108(3), 175-181. doi:10.1016/s1521-6616(03)00144-x
[49]
Hu, T., Tan, Q., Ruan, Y., Ruan, Y., Wang, X., Yao, J., … Wang, J. (2016). Study on the relationship of acute ketosis intoxication and type 2 diabetes mellitus. Journal of Acute Disease, 5(3), 232-236. doi:10.1016/j.joad.2016.03.011
[50]
Newton, C. A., & Raskin, P. (2004). Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus. Archives of Internal Medicine, 164(17), 1925. doi:10.1001/archinte.164.17.1925
[51]
Anjana, R. M., Shanthirani, C. S., Unnikrishnan, R., Mugilan, P., Amutha, A., Nair, H. D., … Mohan, V. (2014). Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study. Acta Diabetologica, 52(3), 601-609. doi:10.1007/s00592-014-0701-0
[52]
McFarlane, S. I., Chaiken, R. L., Hirsch, S., Harrington, P., Lebovitz, H. E., & Banerji, M. A. (2001). Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabetic Medicine, 18(1), 10-16. doi:10.1046/j.1464-5491.2001.00395.x
[53]
Umpierrez, G., Smiley, D., Gosmanov, A., & Thomason, D. (2007). Ketosis-Prone Type 2 Diabetes: Effect of Hyperglycemia on β-Cell Function and Skeletal Muscle Insulin Signaling. Endocrine Practice, 13(3), 283-290. doi:10.4158/ep.13.3.283
[54]
Maldonado, M. R., Otiniano, M. E., Cheema, F., Rodriguez, L., & Balasubramanyam, A. (2005). Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function. Diabetic Medicine, 22(12), 1744-1750. doi:10.1111/j.1464-5491.2005.01724.x
[55]
Nalini, R., Gaur, L. K., Maldonado, M., Hampe, C. S., Rodriguez, L., Garza, G.,… Balasubramanyam, A. (2008). HLA Class II Alleles Specify Phenotypes of Ketosis-Prone Diabetes. Diabetes Care, 31(6), 1195-1200. doi:10.2337/dc07-1971
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186